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During the last several decades, industrializa­
tion and urbanization have resulted in dra­
matic increases in vehicle­associated emissions. 
More than 50% of the total particulate matter 
(PM) emissions in urban areas are related to 
road traffic (Briggs et al. 1997). A number 
of studies have reported significant associa­
tions between traffic density or proximity to 
roads and various respiratory symptoms in 
children (Brunekreef et al. 1997; Edwards 
et al. 1994; Venn et al. 2001). A recent study 
from London reported that asthmatic indi­
viduals showed increased symptoms (lung 
dysfunction and inflammation) while walk­
ing around heavily trafficked Oxford Street 
compared with performing similar activities in 
Hyde Park (McCreanor et al. 2007). In addi­
tion, increased cardiovascular effects have also 
been reported with environmental exposure to 
vehicular­traffic–derived pollutants (Dockery 
et al. 2005; Peters et al. 2004).
Roadside aerosols are a complex mixture of 
different size particles that segregate into three 
fractions. Coarse PM [2.5–10 µm in aero­
dynamic diameter (PM2.5–10)] is produced by 
abrasion of automobile brakes and tires and 
dispersion of road dust, whereas fine (PM2.5) 
and ultrafine (PM0.1) materials are emitted 
directly from the tail pipe or form as second­
ary aerosols through atmospheric reactions. 
Vehicle emission factors have been estimated 
from dynamometer emission monitoring, 
as well as from locational studies of tunnels 
and near­roadside environments (Kuhn et al. 
2005; Phuleria et al. 2006; Riddle et al. 2008). 
These studies have reported larger PM emis­
sions from diesel trucks compared with gaso­
line vehicles, with higher levels of direct vehicle 
emissions related to proximity to the roadside. 
Because the physicochemical characteristics 
of roadside airborne particles are also influ­
enced by factors such as location, climatic 
conditions, traffic volumes, type of fuel and 
engine, and operating conditions, the toxic 
potential of these mixtures can be quite diverse 
(DeMarini et al. 2004; Gilmour et al. 2007; 
Kleinman et al. 2007; Seagrave et al. 2002; 
Singh et al. 2004). Direct exposure to com­
bustion emissions has resulted in a wide vari­
ety of cardio  pulmonary effects in animals and 
human volunteers (reviewed by Hesterberg 
et al. 2009; Lewtas 2007; Sydbom et al. 2001). 
Furthermore, many of these pathophysiologic 
changes have also been noted after inhalation 
exposure to ambient PM (Brook et al. 2002; 
Gong et al. 2003; Gurgueira et al. 2002; 
Samet et al. 2009; Sun et al. 2005), sometimes 
in association with traffic­related pollution. 
We designed the present study to characterize 
the chemical composition of size­fractionated 
airborne PM collected at either 20 or 275 m 
from an interstate highway and to determine 
the cardio  pulmonary toxicity of the particles 
after oro  pharyngeal aspiration in mice.
Materials and Methods
Sample collection. We collected two consecu­
tive weekly samples of airborne PM in three 
different size ranges (coarse, 2.5–10 µm; 
fine, 0.1–2.5 µm; ultrafine, < 0.1 µm) using 
ChemVol high­volume cascade impactors 
(model 2400, Rupprecht & Patashnick 
Co. Inc., Albany, NY) during the weeks of 
26–31 July and 3–10 August 2006. Sampling 
sites were located approximately 20 m and 
275 m from the nearest travel lane of a high­
way in Raleigh, North Carolina, and are 
referred to as the near road (NR) and far road 
(FR) sites, respectively. The sites were cho­
sen based on prevalent wind direction and 
distance from the highway and represented 
potentially high and low exposure to pollu­
tion emitted by traffic on the adjacent high­
way (Kuhn et al. 2005; Riddle et al. 2008). 
The vehicle fleet mix at the highway consisted 
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Ba c k g r o u n d: Epidemiologic studies have reported an association between proximity to highway 
traffic and increased cardiopulmonary illnesses.
oBjectives: We investigated the effect of size-fractionated particulate matter (PM), obtained at 
different distances from a highway, on acute cardiopulmonary toxicity in mice.
Me t h o d s : We collected PM for 2 weeks in July–August 2006 using a three-stage (ultrafine, 
< 0.1 µm; fine, 0.1–2.5 µm; coarse, 2.5–10 µm) high-volume impactor at distances of 20 m [near 
road (NR)] and 275 m [far road (FR)] from an interstate highway in Raleigh, North Carolina. 
Samples were extracted in methanol, dried, diluted in saline, and then analyzed for chemical con-
stituents. Female CD-1 mice received either 25 or 100 µg of each size fraction via oro  pharyngeal 
aspiration. At 4 and 18 hr postexposure, mice were assessed for pulmonary responsiveness to 
inhaled methacholine, biomarkers of lung injury and inflammation; ex vivo cardiac pathophysiology 
was assessed at 18 hr only.
re s u l t s: Overall chemical composition between NR and FR PM was similar, although NR samples 
comprised larger amounts of PM, endotoxin, and certain metals than did the FR samples. Each PM 
size fraction showed differences in ratios of major chemical classes. Both NR and FR coarse PM 
produced significant pulmonary inflammation irrespective of distance, whereas both NR and FR 
ultrafine PM induced cardiac ischemia–reperfusion injury.
co n c l u s i o n s: On a comparative mass basis, the coarse and ultrafine PM affected the lung and heart, 
respectively. We observed no significant differences in the overall toxicity end points and chemical 
makeup between the NR and FR PM. The results suggest that PM of different size-specific chemistry 
might be associated with different toxicologic mechanisms in cardiac and pulmonary tissues.
key w o r d s : cardiopulmonary, chemical composition, inflammation, ischemia–reperfusion injury, 
mice, motor vehicle emissions, near road, particulate matter, size fraction. Environ Health Perspect 
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mostly of light­duty, gasoline­powered motor 
vehicles. Detailed description of sampling site 
charac  teristics have been published previously 
(Baldauf et al. 2008). The coarse and fine 
fractions of PM and the ultrafine PM were 
collected onto precleaned, preweighed poly­
urethane foam (PUF) and polypropylene fiber 
filters, respectively. The amount of material 
collected was determined gravimetrically. The 
PM was extracted for chemical analyses and 
toxicity testing.
PM extraction and recovery. For the 
coarse and fine PM fractions, PUF strips were 
transferred to sterile 50­cc polypropylene 
tubes and submerged in 35 mL of analytical­
grade methanol. The tubes were placed in an 
ultrasonic water bath at < 25°C for 1 hr at 
100% power, 25 kHz frequency, and nor­
mal ultrasonic mode (model TI­H15, Elma 
Hans Schmidbauer GmbH & Co. KG, 
Singen, Germany). After sonication, a sterile 
Teflon rod was pressed against the PUF to 
help liberate material in the pores. Extracted 
material was decanted into preweighed sterile 
polypropylene 50­cc tubes. For the ultrafine 
PM fractions, a poly  propylene fiber filter was 
placed in a sterile 4­L glass beaker with the 
PM­collected side downward and submerged 
in 150 mL methanol. The beaker was covered 
with Parafilm and sonicated for 1 hr under 
the same conditions as the PUF filters. The 
extracted material was decanted into a sterile 
250­mL polypropylene bottle. The beaker was 
rinsed with additional volumes of methanol 
and then combined with extracted material. 
Aliquots of all size fractions for each collec­
tion week were evaporated to dryness under 
nitrogen, and the tubes were reweighed. PM 
recovery efficiency was calculated as the dif­
ference between the pre­ and postweight of 
the tubes, divided by the PM mass collected 
on the weekly filters.
After determination of PM mass, the 
dried materials of each sample were dissolved 
in 100% methanol, followed by addition of 
0.9% sterile saline, producing a PM suspension 
containing 0.5% methanol and 10 mg/mL 
PM. A control saline solution contained 0.5% 
methanol. The reconstituted PM suspensions 
and saline were sonicated, vortexed for 1 min, 
and analyzed for chemical constituents; 1­mL 
aliquots of the material were stored at –80°C 
until toxicity testing. For the toxicologic study, 
we combined two weekly PM suspensions of 
the same size fraction and location to produce 
the same mass ratio of collected PM samples 
from the individual weeks.
Chemical analyses of PM. We analyzed 
NR and FR PM samples of each week for 
inorganic elements, ions, and carbon con­
tent. For elemental analysis, 2­mg aliquots of 
PM suspension in saline used for the animal 
exposures were digested in 10% nitric acid 
to solubilize the metals (Wichers et al. 2006). 
Supernatants separated by centrifugation 
were diluted to a final concentration of 1.5% 
HNO3 and then assayed for 28 inorganic ele­
ments by inductively coupled plasma­optical 
emission spectrometry (ICP­OES) using U.S. 
Environmental Protection Agency (EPA) 
Method 200.7, rev4.4 (U.S. EPA 1994). 
For ionic components, 250­µg aliquots of 
the saline PM suspensions were diluted with 
6 mL ultrapure water and analyzed for nitrate, 
sulfate (SO4
2–), chloride, sodium, ammo­
nium (NH4
+), potassium, magnesium, and 
calcium by ion chromatography using EPA 
Compendium Method IO­4.2 (U.S. EPA 
1999) with calibration and quality control 
standards obtained from Dionex Corporation 
(Sunnyvale, CA) and Alltech Associates, Inc. 
(Deerfield, IL). Excessive amounts of sodium 
and chloride were present due to the saline 
in the PM suspension and were not reported 
in the result (Table 1). For carbon analy­
sis, 1­mg aliquots of PM in methanol were 
pipetted onto prefired 1.45­cm2 quartz filters, 
dried, and analyzed by thermo­optical meth­
ods based on sequential pyrolytic vaporization 
and detection by transmittance using a car­
bon analyzer (model 107A; Sunset Laboratory 
Inc., Tigard, OR) (Birch and Cary 1996).
Endotoxin measurements. Particle sus­
pensions in saline were sonicated, vortexed 
for 15 min, and centrifuged for 15 min at 
2,100 rpm. Supernatants were collected 
and diluted in endotoxin­free water at 
PM­equivalent concentrations of 1, 0.1, and 
0.01 mg/mL. Endotoxin measurements were 
performed using the Limulus amoebo  cyte 
lysate assay (QCL­1000; Cambrex BioScience 
Inc., Walkersville, MD).
In vivo toxicity of PM. Experimental ani-
mals. Female CD­1 mice were obtained from 
Charles River Laboratory (Raleigh, NC) and 
housed five per cage in a barrier­isolated ani­
mal facility approved by the Association for 
Assessment and Accreditation of Laboratory 
Animal Care. Food and water were provided 
ad libitum. We used two different groups 
of mice: one for pulmonary assessment and 
blood and tissue collection [n = 7/group (total, 
n = 196); 7–8 weeks of age; body weight, 
29.7 ± 2.3 g], and another for cardiac evalua­
tion [n = 5/group (total, n = 40); 16 weeks of 
age; 33.8 ± 0.8 g]. All animals were treated 
humanely and with regard for alleviation 
of suffering in accordance with National 
Institutes of Health guidelines (Institute of 
Laboratory Animal Resources 1996). 
Pharyngeal aspiration. Surgical anesthesia 
was induced using a commercially available 
system (VetEquip Inc., Pleasanton, CA) to 
generate a 5% isoflurane/oxygen mixture. PM 
suspensions (25 or 100 µg) or the saline vehicle 
were administered by pharyngeal aspiration 
(Gilmour et al. 2007). Similarly, a separate 
group of mice received 2 µg lipopoly  saccharide 
(LPS) (Escherichia coli endotoxin; 011:B4 con­
taining 106 unit/mg material; Sigma, St. Louis, 
MO) as a positive control to demonstrate 
maximal inflammatory response to this well­
characterized inflammatory agent.
Pulmonary responsiveness testing. Two 
hours before euthanasia and necropsy, a sub­
group of mice was challenged with increas­
ing concentrations of methacholine (MCh) 
aerosol in order to determine pulmonary 
responsiveness. We used a 12­chamber whole­
body plethysmograph system using Buxco 
BioSystem XA software (Buxco Electronics, 
Wilmington, NC) to measure ventilatory 
parameters and the enhanced pause (Penh), 
an index of airflow limitation and a surrogate 
for bronchoconstriction (Hamelmann et al. 
1997). After measuring baseline parameters 
for 10 min, an aerosol of saline or 6.25, 12.5, 
or 25 mg MCh/mL saline was pulled through 
each plethysmograph at a constant and identi­
cal flow rate (2 mL/sec). Response to saline 
Table 1. Collected mass and extraction recovery and chemical compositions in PM fractions from NR and 
FR sites, and endotoxin content in particle extract of PM fractions.
NR FR
Coarse Fine Ultrafine Coarse Fine Ultrafine
Collected mass (mg)
  Week 1 66 101 22 55 88 23
  Week 2 74 142 35 56 117 33
Recovery (%)
  Week 1 54 41 87 70 66 88
  Week 2 56 70 68 80 61 101
Ionic components (µg/g)
  Ca2+ 26,779 3,375 4,464 25,200 3,165 2,796
  Mg2+ 2,879 861 1,902 3,076 1,014 1,918
 K + 10,051 1,526 2,687 10,840 1,947 2,711
  NH4
+ 13,819 117,687 153,979 12,975 123,407 157,075
  NO3
– 89,121 7,719 8,078 90,681 7,305 8,751
  SO4
2– 54,982 372,394 465,643 64,916 411,206 511,638
Carbon species
  Total/PM (%) 19.0 22.3 26.3 20.4 20.2 24.4
  Organic (µg/g) 185,455 206,408 261,073 203,073 192,198 243,673
  Elemental (µg/g) 4,858 17,038 1,740 508 9,353 0
Endotoxin (EU/g) 253 7 2 102 1 1Cho et al.
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and MCh was measured for 10 min, both dur­
ing the 2­min aerosolization period and then 
for 8 min afterward. A MCh dose–response 
curve was then constructed for each animal. In 
addition, by interpolating the dose–response 
curve, the concentration of MCh required 
to produce a doubling of the Penh from the 
saline (EC200) was calculated for each animal.
Biological sample collection and hematol-
ogy. At 4 or 18 hr postaspiration, mice from 
each treatment group were euthanized and 
plasma was obtained by cardiac puncture using 
a 1­mL syringe containing 50 µL EDTA acid as 
anti  coagulant. The trachea was cannulated and 
the left main stem bronchus occluded while 
the right lung lobes were lavaged once with 
3 vol of 0.6 mL (35 mL/kg) Hank’s balanced 
salt solution (HBSS) maintained at 37°C. The 
recovered broncho  alveolar lavage fluid (BALF) 
was centrifuged at 130 × g for 10 min at 4°C 
with an aliquot stored at either 4°C for bio­
chemical measurement or –80°C for cytokine 
measure  ment. Cell pellets were resuspended in 
1 mL HBSS. Total BALF cell count for each 
mouse was measured with a Coulter Counter 
(Beckman, CA). Samples (200 µL) were pre­
pared in duplicate onto slides using a Cytospin 
(Shandon, PA) and stained with HEMA 3 
stain set (Fisher Diagnostics, Middletown, VA) 
for cell differentiation determination using 
light microscopy. Hematologic data including 
total white blood cells, total red blood cells, 
hemoglobin, hematocrit, mean corpuscular 
volume, mean corpuscular hemoglobin con­
centration, platelets, and lymphocytes were 
measured using a Coulter AcT 10 Hematology 
Analyzer (Beckman Coulter Inc., Miami, FL). 
Residual blood samples were centrifuged and 
processed to plasma for subsequent clinical 
chemistry analyses.
Cytokine measurements. Concentrations 
of the pro  inflammatory cytokines macrophage 
inhibitory protein­2 (MIP­2), tumor necrosis 
factor­α (TNF­α), and interleukin­6 (IL­6) 
in BALF were measured by enzyme­linked 
immunosorbent assay using mouse Quantikine 
kits (R&D Systems, Minneapolis, MN). The 
lowest value in the standard curve for each 
cytokine was 15.625, 19.531, and 15.625 pg/
mL for MIP­2, TNF­α, and IL­6, respectively, 
and all values below these lowest values were 
replaced with a fixed value of one­half of the 
lowest value.
BALF and plasma biochemistry. Lactate 
dehydrogenase (LDH), micro  albumin, 
N­acetyl­β­d­glucoaminidase, and total protein 
were determined in BALF. Creatine kinase, 
amino­S­transferase (AST), alanine trans­
aminase (ALT), LDH, α1 anti  trypsin (A1AT), 
hapto  globin (HPT), C­reactive protein 
(CRP), and fibrinogen (FIB) were analyzed in 
plasma. All biochemical assays were modified 
for a Konelab 30 clinical chemistry analyzer 
(Thermo Clinical Labsystems, Espoo, Finland), 
as previously described (Gilmour et al. 2007).
Cardiac perfusion. We used a separate 
group of mice for assessment of cardiac toxic­
ity. Mice aspirated 100 µg each of coarse, fine, 
or ultrafine PM collected from both NR and 
FR collection sites. At 18 hr  post  aspiration 
of PM, ex vivo Langendorff cardiac perfusion 
and subsequent ischemia reperfusion were per­
formed as described previously (Tong et al. 
2009). The Langendorff perfusion model has 
been used to investigate cardiac responses after 
PM exposure in experimental animal studies 
(Bagate et al. 2006; Wold et al. 2006). We 
used the PowerLab system (AD Instruments, 
Milford, MA) to collect and process the left 
ventricular developed pressure (LVDP), heart 
rate, maximum of the first derivative of left 
ventricular pressure rise (+dP/dtmax), and mini­
mum of the first derivative of left ventricular 
pressure fall (–dP/dtmin) data. One heart did 
not achieve a developed pressure of at least 
90 cm H2O and was excluded from data analy­
sis. Coronary flow rates were measured before 
and after induced ischemia reperfusion. After 
ischemia reperfusion, recovery of cardiac func­
tion and infarct size were measured at 1 and 
2 hr of reperfusion, respectively. A detailed 
procedure of necrosis evaluation has been 
described by Tong et al. (2009).
Statistical analysis. We analyzed data in 
three increments. Initially, we performed a two­
way analysis of variance (ANOVA) to evaluate 
BALF and plasma data, and we used a three­
way ANOVA to evaluate the Penh data. These 
models examined overall effects of particle 
size (coarse, fine, and ultrafine) and sampling 
location (NR and FR sites) in the two­way 
ANOVA, or the influence of particle size, 
sampling location, and MCh concentration 
[levels: –1 (baseline), 0 (saline), 6.25 (6.25 mg 
MCh/mL saline), 12.5 (12.5 mg MCh/mL 
saline), and 25 (25 mg MCh/mL saline)] in the 
three­way ANOVA. Control exposure groups 
(saline and LPS) were not included in this 
analysis. The second step employed a one­way 
ANOVA model using an independent variable 
formed by combining location and size into 
a single treatment group parameter, and the 
saline control was included in the model. In the 
third step we used Dunnett’s test to compare 
the effect between each PM­exposed group 
and saline control group, adjusting significance 
level for multiple comparison. All the data were 
analyzed separately by each post  exposure time 
period and PM dose. Significance was assigned 
at p < 0.05. 
Results
Particle characteristics. Table 1 shows the col­
lected particle masses and recovered fractions 
after extraction from two weekly samples from 
each sampling location, as well as the chemical 
analyses. Approximately 20% more total PM 
mass was collected at the NR site than at the 
FR site. Coarse and fine NR PM masses were 
27% and 20% greater, respectively, than cor­
responding fractions of FR PM; we found no 
difference in ultrafine fractions. The percent 
recovery ranges of size­fractionated PM after 
methanol extraction and evaporation were 
54–80%, 41–70%, and 68–101% for the 
coarse, fine, and ultrafine PM samples, respec­
tively. The percent recoveries were relatively 
higher for FR PM and showed greater consis­
tency between weekly samples compared with 
NR PM. Losses likely occurred from particles 
remaining in the filter substrates as well as 
during the extraction procedure.
Calcium (Ca2+), potassium (K+), and 
nitrate (NO3
–) were much enriched in the 
coarse fractions, whereas SO4
2– and NH4
+ 
were more abundant in the fine and ultra­
fine fractions. The ion chromatography anal­
yses of calcium and SO4
2–contents showed 
good agreement with elemental analysis using 
ICP­OES. Calcium levels were 1.6 times 
higher in the ultrafine fraction of NR PM 
compared with the FR sample. The total car­
bon consisted of 19–22% of total mass of 
coarse and fine PM and 24–26% of ultrafine 
PM without apparent difference by location. 
Organic carbon amount ranged between 19% 
and 26%, with similar levels at both locations. 
Elemental carbon content was therefore much 
lower than the organic carbon and was mostly 
Table 2. Inorganic elemental constituents of coarse, fine, and ultrafine fractions of PM collected at NR and FR sites (µg/g of PM).
Al Ba Ca Cd Cr Cu Fe K Mg Mn Ni Pb SO4 Sb Si Sn Sr Ti V Zn
NR
  Coarse 12,000a 1,400c 22,000 14a 48b 790c 19,000b 11,000 6,500 510a 33 59b 57,000 110c 32,000a 33 110 970 61 990c
  Fine 3,600 340c 3,600 11 18a 250c 5,500b 3,100 1,400 130 23 67 370,000 54c 9,200 76 34 170c 42a 520a
  Ultrafine 1,900 10c 4,500b 18 13 150a 1,700a 5,900 900 100 30 69 440,000 47 340c 21 23a 31b 54 920
FR
  Coarse 9,000 540 20,000 11 31 320 10,000 9,900 6,000 390 27 39 63,000 41 24,000 32 100 960 63 400
  Fine 3,700 120 3,200 10 14 100 3,000 3,600 1,600 110 23 75 440,000 24 8,100 131b 30 74 33 400
  Ultrafine 1,800 3 2,600 16 11 110 1,300 5,500 800 90 32 87a 450,000 42 170 44c 16 20 58 980
NR PM as a percentage of corresponding FR PM: a130–150%; b150–200%; c> 200%. Cardiopulmonary toxicity of roadside PM
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enriched in the fine fractions. The sum of ele­
mental carbon in all fractions of NR PM was 
2.4 times higher than that of FR PM. With 
regard to biogenic components, the coarse PM 
contained approximately 100 times higher 
levels of water­soluble endotoxin than did the 
fine and ultrafine PM, and the NR coarse PM 
had 2 times more meas  ureable endotoxin than 
did the FR coarse PM.
Table 2 shows the inorganic elemental 
constituents of each size fraction from both 
locations. The concentrations of elements 
contained in NR PM [aluminum (Al), barium 
(Ba), calcium (Ca), cadmium (Cd), chromium 
(Cr), copper (Cu), iron (Fe), manganese 
(Mn), lead (Pb), antimony (Sb), silicon (Si), 
strontium (Sr), titanium (Ti), vanadium (V), 
zinc (Zn)] were at least 30% higher per gram 
of PM mass in any of three size fractions than 
in the FR PM. Lead (Pb) and tin (Sn) were 
present in relatively higher concentrations in 
the FR fine and ultrafine samples than in the 
NR samples.
Figure 1 shows the mass balance of major 
classes of chemical components from each 
saline­suspended PM sample used for pharyn­
geal aspiration in mice. Overall, the chemi­
cal profile of the coarse fraction had a pattern 
different than that of the fine and ultrafine 
fractions, whose relative proportions of the 
major chemical classes were quite similar. 
Furthermore, none of the ratios of these major 
classes was appreciably altered by location. 
Unidentified moieties increased with particle 
size: 12–13% for ultrafine PM, 20–25% for 
fine PM, and 54–55% for coarse PM. These 
were presumably mineral components such as 
refractory alumino  silicates and associated alkali 
and oxygen components, which, unlike the 
anthropogenic metals, did not fully dissolve in 
nitric acid.
Inflammatory biomarkers in BALF. With 
the exception of cytokines, which peaked 
at the 4­hr time point, all other markers of 
injury and inflammation were highest at 18 hr 
post  aspiration. Saline aspiration produced no 
apparent increase in markers compared with 
historic untreated control data, whereas LPS­
treated animals had high values of inflamma­
tion, cytokines, and markers of lung injury. 
The overall statistical analysis of numbers 
of poly  morpho  nuclear neutrophils (PMNs) 
by two­way ANOVA showed a significant 
particle size effect but no sampling location 
effect. At 18 hr post  exposure, for the 100­µg 
dose, the PMN numbers were significantly 
higher in the coarse PM­exposed groups com­
pared with the saline group regardless of sam­
pling location, comprising 34–39% of the 
total cells (Figure 2), whereas the 25­µg PM 
dose did not induce a significant effect. We 
observed no significant increases in PMNs 
for any of the fine or ultrafine PM at either 
concentration or location. Lymphocyte num­
bers were also significantly increased (< 1% 
of the total cells) at 18 hr postexposure to the 
FR coarse PM of 100 µg but not by the NR 
coarse PM (data not shown). We found no 
significant differences in numbers of alveolar 
macrophages between the various treatment 
groups, although we did detect particles in the 
alveolar macrophages from PM­exposed mice.
Overall, the production of cytokines 
increased in a dose­dependent manner. The 
analysis of inflammatory cytokines by two­
way ANOVA showed a particle size effect for 
MIP­2, TNF­α, and IL­6. At 4 hr (Figure 3), 
both the 100­µg and 25­µg doses of NR and 
FR coarse PM significantly increased the 
production of the MIP­2 and TNF­α. The 
responses to both NR and FR coarse PM 
were still significant with the 100­µg dose at 
18 hr and to a lesser extent with the 25 µg 
(TNF­α only; data not shown). We found no 
significant differences for the other size frac­
tions of any doses at any time points. At 4 hr 
(Figure 3), IL­6 was significantly increased 
with the high­dose coarse samples from both 
locations, and this effect persisted at 18 hr 
for the FR­sample (data not shown). LPS 
responses were much higher than PM at the 
4 hr, indicating that the mice were capable of 
responding to an inflammatory agent.
The overall statistical analysis of lung 
injury end points showed no significant effect 
by either particle size or sampling location. 
Analysis of individual treatment groups indi­
cated that only total protein in BALF was 
increased at a small but significant degree with 
the 100­µg NR coarse PM at the 18 hr post­
exposure (Figure 4). LPS treatment showed a 
clear increase in BALF protein concentrations 
over saline controls at 18 hr. For complete data 
for pulmonary markers and responsiveness to 
MCh see Supplemental Material, Table S1 
(doi:10.1289/ehp.0900730.S1 via http://
dx.doi.org/).
Hematologic markers in whole blood and 
plasma. We monitored a variety of cellu  lar 
and humoral markers in whole blood and 
plasma. The overall analysis by two­way 
ANOVA showed no significant effect by 
either particle size or location. In subsequent 
analyses, we found that the NR coarse PM 
Figure 1. Mass balances (%) of major classes of chemical components in each fraction of NR and FR PM 
in the saline suspension used for pharyngeal aspiration on mice.
NR ultraﬁne NR coarse NR ﬁne
FR ultraﬁne FR coarse FR ﬁne
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Figure 2. Number of neutrophils in BALF 18 hr post­
exposure to NR and FR PM (n = 7 mice/group). 
Abbreviations: C, coarse; F, fine; SAL, saline; U, 
ultrafine. Error bars indicate SE.
**p < 0.01 compared with saline. 
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sample caused a significant increase in creatine 
kinase in the plasma at 4 hr post  exposure 
(data not shown), indicating systemic effects 
after aspiration with this material. We found 
no significant changes in cell numbers, plate­
lets, or hematocrit markers or in plasma con­
centrations of A1AT, ALT, AST, CRP, FIB, 
HPT, or LDH.
Pulmonary responsiveness testing. The 
overall analysis of MCh responsiveness by 
three­way ANOVA indicated a significant 
effect by particle size and MCh dose. In the 
subsequent analyses, animals exposed to 
100 µg of either NR or FR coarse PM showed 
significantly enhanced pulmonary responsive­
ness to the 12.5 mg/mL MCh dose at 18 hr 
post  exposure compared with the saline group 
(Figure 5A). The 25­mg/mL MCh dose also 
enhanced pulmonary responsiveness but not 
to a significant level. When the data were 
transformed to reflect the EC200 (Figure 5B), 
we detected no statistical significance for the 
location and size factors. Nevertheless, mice 
exposed to 100 µg coarse PM required a non­
significant but notably lower dose of MCh to 
achieve a 100% increase in Penh compared 
with the saline group.
Cardiac ischemia–reperfusion injury. 
To examine the cardiac effects of the various 
PM samples, we isolated hearts at 18 hr after 
aspiration of 100 µg PM, and perfused and 
evaluated them for baseline hemo  dynamics 
before under  going ischemia reperfusion. The 
baseline hemo  dynamics are shown in Table 3. 
The coronary flow rates in the NR fine and 
ultrafine groups were significantly lower than 
that of the saline group. We also found a 
notable but non  significant reduction in the 
coronary flow rate in the FR ultrafine group. 
We observed increases in baseline LVDP and 
+dP/dtmax, and decreases in –dP/dtmin in the 
coarse and ultrafine groups of both NR and 
FR PM, but these were not significant.
After ischemia reperfusion, the FR ultra­
fine group showed significantly lower recov­
ery of postischemic LVDP (Figure 6A) and 
increased infarct size (Figure 6B) compared 
with the saline controls. For representative 
photomicrographs, see Supplemental Material, 
Figure S1 (doi:10.1289/ehp.0900730.S1). 
The NR ultrafine group also showed similar 
responses at a non  significant level. The coarse 
PM groups showed the smallest changes fol­
lowed by fine PM groups, indicating these 
effects were dependent on particle size frac­
tion. Overall, the results showed that ultrafine 
PM exposure increased ischemia–reperfusion 
injury in the mouse heart.
Discussion
Many studies have compared the physico­
chemical characteristics and relative toxicity 
of size­fractionated PM from different sources 
and locations. In general, coarse PM obtained 
from ambient air sampling contains larger 
amounts of bacterial endotoxin and insoluble 
crustal components than smaller size fractions 
of PM and, on a mass basis, have more pro­
inflammatory potential than do fine or ultra­
fine fractions (Becker et al. 2005; Dick et al. 
2003; Gilmour et al. 2007; Happo et al. 2007). 
Combustion aerosols in the fine and ultra­
fine modes can also generate significant lung 
inflammation (Gilmour et al. 2004; Seagrave 
et al. 2005; Singh et al. 2004), whereas simple 
chemicals such as carbon black and titanium 
dioxide tend to cause stronger effects as sur­
face area increases and size decreases (reviewed 
by Donaldson et al. 1998). These results sug­
gest that inflammatory potential is dependent 
on both chemistry and particle size, and that 
effects may vary depending on the method 
of collection, freshness of the sample, and 
coconstituents. Near roadway environments 
are of particular interest because they com­
prise an array of freshly generated and aged 
particles that coexist in each of the three broad 
size ranges. Although it has been known for 
some time that the size, number concentration, 
and chemistry of PM change with distance 
from highways (Kuhn et al. 2005), toxicity 
data for PM samples from different proximities 
to roadways have only recently been examined. 
Kleinman et al. (2007) recently reported that 
NR (50 m) emissions in the fine and ultra  fine 
range significantly enhanced allergic responses 
in sensitized animals compared with expo­
sures that occurred at FR locations (150 m). 
However, toxicity data simultaneously compar­
ing cardiac and pulmonary effects after expo­
sure to each of the size fractions from NR and 
FR locations require further investigation.
Traffic­associated airborne particles feature 
a tri  modal size distribution typically found in 
other ambient samples and display a distinct 
chemical profile related to the vehicle fleet 
mix, operating conditions, meteorology, dis­
tance from highway, and presence of other air 
pollutants. In this study, NR PM was more 
enriched with inorganic elemental compounds 
than FR PM. Specifically, the coarse NR PM 
fraction contained more Ba, Cu, Sb, Zn, 
Fe, Pb, and Cd, which have been attributed 
to brake and tire wear (Querol et al. 2007; 
Wåhlin et al. 2006), and Al, Mn, and Si, asso­
ciated with road dust, asphalt, and concrete. 
The fine and ultrafine fractions of NR PM 
contained larger amounts of Ba, Ca, Fe, Si, Sb, 
Ti, and V compared with FR PM. Along with 
some overlap with coarse PM, these elements 
are also components of lubricating and fuel oils 
(Dyke et al. 2007) and are emitted in vehicle 
exhaust (McDonald et al. 2004). The enrich­
ment of these elements in NR PM indicated a 
significant contribution of traffic­related PM, 
whereas the high SO4
2– concentrations in the 
fine and ultrafine fractions at both locations 
likely reflected locally generated traffic emis­
sions as well as the regional pollutant profile 
consistent with the chemical makeup of fine 
PM in the eastern United States (U.S. EPA 
2008). Relatively small amounts of elemental 
carbon in NR PM reflected most of the vehicle 
fleet at the highway being gasoline­powered 
vehicles (Baldauf et al. 2008).
The toxicity results showed that inflam­
matory responses in mice were increased in 
a dose­dependent manner after aspiration of 
coarse PM samples, whereas treatment with 
equal masses of the smaller particles had much 
less effect. These findings are in agreement with 
previous reports from different cities across the 
United States and Europe that employed this 
sampling methodology and type of bioassay 
(Dick et al. 2003; Gilmour et al. 2007; Happo 
et al. 2007; Hetland et al. 2005). It should be 
noted that more coarse and fine PM collected 
Figure 3. Proinflammatory cytokines of MIP­2, TNF­α, and IL­6 in BALF 4 hr postexposure to NR and FR PM (n = 7 mice/group). Abbreviations: C, coarse; F, fine; 
SAL, saline; U, ultrafine. Error bars indicate SE.
*p < 0.05, and **p < 0.01 compared with saline.
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at the NR location over the same sampling 
period would have resulted in a greater cumu­
lative exposure compared with FR location, 
whereas the experimental exposure regimen 
described here was designed to compare toxic­
ity on an equal mass basis. Furthermore, traf­
fic­associated gases and volatile compounds 
that were not collected by the PM samplers are 
steadily diluted with distance from the roadway 
(Baldauf et al. 2008) and may be major con­
tributors to reported health effects associated 
with proximity to roadways.
Much of the proinflammatory effect we 
observed from coarse PM was likely caused 
by the presence of LPS, whereas the smaller 
sized PM samples that produced no inflamma­
tion contained very little LPS. The NR coarse 
sample had twice as much LPS as did the FR 
course sample per gram of material but did 
not have substantially increased toxicity, sug­
gesting that the effects were not solely driven 
by this substance. In addition to LPS, the 
coarse PM comprised many other soluble and 
insoluble components capable of activating 
lung cells and inducing chemo  tactic mediators 
with the subsequent recruitment of inflam­
matory cells (Hetland et al. 2004). Chemical 
and source apportionment analysis from the 
European study indicated that other compo­
nents, including sea salt, soil­related elements, 
indicators of traffic, and nitrates, were also 
related to the inflammatory responses of coarse 
PM (Happo et al. 2007, 2008).
In agreement with the reports mentioned 
above, in the present study aspiration of fine 
or ultrafine PM caused little in the way of 
pulmonary inflammation despite the dose 
being as high as 100 µg per mouse. Because 
equivalent dosing of source­derived material, 
including fine and ultrafine coal fly ash, die­
sel exhaust particles, and oil fly ash (Gavett 
et al. 1999; Gilmour et al. 2004; Singh et al. 
2004), produce varying degrees of pulmo­
nary inflammation, this would suggest either 
that the fine and ultrafine ambient PM sam­
ples were less toxic than these source­specific 
PM samples, or that the atmospheric aging, 
collection and extraction procedures, or the 
presence of coconstituents reduced the   activity 
of the sample.
In contrast to the pulmonary responses, 
the fine and ultrafine PM caused a decrease in 
coronary flow rate; after ischemia reperfusion, 
recovery of cardiac function was decreased; and 
the infarct size was increased by ultrafine PM. 
Previous studies have also reported decreases 
in vascular function and post  ischemic recovery 
with exposure to urban ambient ultrafine PM 
(Cozzi et al. 2006) and traffic­related ultrafine 
PM (Hwang et al. 2008; Peretz et al. 2008) in 
human volun  teers and animals. Overall, the 
results suggest that ambient ultrafine PM has a 
higher potential to cause vascular dysfunction 
and cardiac damage than other size fractions 
and provides experimental support for recent 
epidemiologic and clinical reports (reviewed by 
Brook et al. 2004; Mills et al. 2009). There was 
also some suggestion that the NR ultrafine PM 
had greater effects on vascular function, but the 
FR ultrafine PM caused slightly more cardiac 
tissue damage after ischemia. Possibly these 
differences could be explained by the higher 
concentrations of elemental carbon at the NR 
location with increased amounts of hetero­
geneous organic aerosols (presumably second­
ary organic aerosols) at the distant location 
as has been previously reported (Kuhn et al. 
2005; Riddle et al. 2008).
Although we did not observe cardiac effects 
for every particle size and location, the results 
illustrate that extrapulmonary responses can 
occur after fine or ultrafine PM exposure in the 
Figure 5. Changes in respiratory responsiveness after MCh inhalation, measured by whole­body plethys­
mographs 18 hr after aspiration of 100 µg PM (n = 7 mice/group). (A) Penh. (B) MCh concentration produc­
ing a doubling of the Penh compared with saline vehicle. Abbreviations: Base, baseline; C, coarse; F, fine; 
SAL, saline; U, ultrafine. Error bars indicate SE.
*p < 0.05 compared with saline aspiration treatment.
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Table 3. Hemodynamics at the end of the control period before the ischemia reperfusion.
Coronary flow 
rate (mL/min) LVDP (cm H2O)
+dP/dtmax 
(mm Hg/sec)
–dP/dtmin  
(mm Hg/sec) Heart rate (bpm)
NR
  Coarse 2.9 ± 0.6 131 ± 12 4,387 ± 306 –4,267 ± 571 380 ± 41
  Fine 2.0 ± 0.7* 119 ± 15 4,093 ± 748 –3,846 ± 1,374 333 ± 42
  Ultrafine 1.7 ± 0.7* 144 ± 11 4,663 ± 422 –4,327 ± 305 378 ± 22
FR
  Coarse 3.2 ± 1.5 141 ± 10 4,933 ± 394 –5,017 ± 481 416 ± 10
  Fine 3.0 ± 1.4 151 ± 25 4,517 ± 955 –3,223 ± 339 358 ± 29
  Ultrafine 2.5 ± 0.7 150 ± 9 4,870 ± 125 –4,129 ± 419 389 ± 18
Saline 3.9 ± 1.4 113 ± 4 3,877 ± 295 –3,045 ± 381 412 ± 17
bpm, beats per minute. PM­exposed animals aspirated 100 µg PM.
*p < 0.05 compared with the saline group.
Figure 6. Post­ischemia–reperfusion cardiac end points in mice treated with 100 µg PM compared 
with saline control mice 18 hr postexposure (n = 5 mice/PM treatment group; n = 10 mice/saline group). 
(A) Recovery of LVDP. (B) Infarction. Abbreviations: C, coarse; F, fine; U, ultrafine. Error bars indicate SE.
*p < 0.05 compared with saline.
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Figure 4. Total protein in BALF at 18 hr post­
aspiration of both NR and FR PM (n = 7 mice/group). 
Abbreviations: C, coarse; F, fine; SAL, saline; U, 
ultrafine. Error bars indicate SE.
*p < 0.05 compared with saline.
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absence of detectable lung inflammation and 
injury. Several human exposure studies have 
shown that fine and ultrafine PM affects cardio­
vascular responses without significant effects 
on the respiratory tract (Gong et al. 2003; 
Samet et al. 2009). In one specific experimen­
tal example, inhalation of zinc sulfate did not 
cause lung injury in rats, but the soluble metal 
translocated to the cardiac tissue and inhibited 
phosphatases and kinase activation with subse­
quent effects on cardiac function (Wallenborn 
et al. 2008, 2009). It has also been demon­
strated that insoluble ultrafine PM can trans­
locate from the lungs to the circulation and be 
detected in other organs, including heart and 
liver (Furuyama et al. 2009; Takenaka et al. 
2004). PM or its soluble constituents may be 
able to induce vaso  constriction by increasing 
endothelin release (Brook et al. 2002; Cozzi 
et al. 2006; Peretz et al. 2008). Reactive oxy­
gen species (ROS), contained in the PM or 
endogenously generated in the lungs and heart, 
could also result in tissue damage (Gurgueira 
et al. 2002), which would decrease an ability to 
recover cardiac function and increase myocar­
dial infarction after ischemia. Also ROS could 
affect the nitric oxide pathway and further con­
tribute to the progression of atherosclerosis or 
other ROS (Sun et al. 2005).
On an equivalent mass basis, significant 
pulmonary and cardiac effects were observed 
with the coarse and ultrafine PM samples, 
respectively; however, in reality, unequal 
mass distributions for the different size frac­
tions would likely affect the extent of toxicity. 
Particle penetration and deposition efficiency 
after aspirations exposure would also not 
reflect site­specific tissue doses after inhala­
tion of hetero  geneous aerosols (Foster et al. 
2001). These challenges can be overcome in 
toxicologic and clinical studies by develop­
ing advanced exposure techniques to separate, 
characterize, and deliver different­sized par­
ticles and accompanying gases from complex 
air pollution atmospheres in order to improve 
understanding of the physico  chemical basis of 
air pollution health effects.
Conclusions
On a comparative mass basis, mice exposed 
to coarse PM from sites proximal to a high­
way showed significant increases in neutrophils, 
IL­6, MIP­2, TNF­α, and protein in BALF 
and altered pulmonary function in healthy 
mice with no noticeable effects on the heart. 
Meanwhile, the same dose of ultrafine PM 
affected the cardiac system in the absence of 
any pulmonary responses. Chemical analyses 
showed clear compositional difference between 
coarse PM and smaller PM but less overall 
changes in the mass balance between NR and 
FR locations and little in the way of altered 
biological effects. However, the higher levels of 
coarse and fine PM (as well as gases and vapors) 
next to the highway would presumably have 
resulted in increased exposure and potential for 
more severe health effects. Further studies are 
needed to examine real­time toxicity of NR and 
FR atmospheres to identify the levels and types 
of particle and gas phase components that cause 
health effects in multiple organ systems. This 
type of work will ultimately expand knowledge 
on the chemical composition and health effects 
of air pollution mixtures between NR and FR 
sites and could be used to improve human 
health risk assessment and provide guidance for 
planning of new roads and communities.
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